Par Drugs & Chemicals Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, hit its lower circuit at Rs 127.66, marking a 4.99% decline — the maximum daily loss allowed under the 5% price band. This price band restricts the daily movement to 5%, and in this case, the circuit breaker intervened to halt further decline. The unfilled supply is evident as sellers queued at this floor price, but buyers remained absent, effectively freezing trading. This scenario typifies a lower circuit event where supply overwhelms demand to the point where the exchange must step in to prevent further losses. Par Drugs & Chemicals Ltd thus found itself trapped at this level, unable to trade lower but also unable to clear the selling pressure — how sustainable is this price floor given the persistent supply?

Delivery and Volume Analysis

Interestingly, delivery volume on 9 Sep 2026 was zero, representing a 100% decline against the 5-day average delivery volume. This suggests that the selling pressure on the previous day was not driven by holders liquidating their positions but possibly by speculative short-selling or intraday trades. On the day of the circuit lock, total traded volume was 0.28156 lakh shares with a turnover of Rs 0.36 crore, reflecting the mechanical volume suppression typical of a circuit lock scenario. The delivery data on a lower circuit day has a specific meaning — and it's not the same as on an upper circuit. Here, the falling delivery volume indicates that genuine holder capitulation was not the primary driver, but rather speculative activity dominated the session — does this imply the selling pressure may ease if holders remain sidelined?

Intraday Price Action

The intraday range was narrow, with the stock opening and closing at Rs 127.66, the circuit price. The high and low price for the day were identical, indicating that the stock opened near the circuit and remained locked there throughout the session. This lack of price movement suggests that demand was absent from the outset, and sellers were unable to find buyers at any price above the floor. The absence of any intraday bounce or recovery highlights the persistent selling pressure and the lack of liquidity — does this price action signal exhaustion or a deeper liquidity trap?

Moving Averages and Trend Context

Technically, the stock trades below its 5-day moving average but remains above the 20-day, 50-day, 100-day, and 200-day moving averages. This mixed moving average configuration indicates that while short-term momentum is weak, the medium to long-term trend has not yet fully broken down. The dip below the 5-day MA confirms immediate selling pressure, but the higher longer-term averages may offer some technical support in the coming sessions. This technical setup suggests a fragile equilibrium where short-term weakness is evident but longer-term trend confirmation is pending — does the technical profile of Par Drugs & Chemicals Ltd show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of Rs 157.08 crore, Par Drugs & Chemicals Ltd is classified as a micro-cap stock. The liquidity profile is modest, with a trade size of Rs 0.05 crore based on 2% of the 5-day average traded value. While this indicates some tradability, the lower circuit lock highlights the exit risk for holders. Sellers face significant friction exiting positions as buyers remain absent at the floor price, potentially leading to multi-day circuit locks if selling pressure persists. This liquidity constraint is a critical factor for micro-cap stocks at lower circuit — how deep is the exit problem for Par Drugs & Chemicals Ltd and what would need to change for normal trading to resume?

Fundamental Context

Operating within the Chemicals & Petrochemicals sector, Par Drugs & Chemicals Ltd is a micro-cap entity with a market cap of Rs 157.08 crore. While fundamentals are not the focus of this price action analysis, the sector's cyclical nature and the company's size contribute to the volatility and liquidity challenges observed. The stock underperformed its sector by 5.09% on the day, while the Sensex declined marginally by 0.02%, underscoring the stock-specific nature of the sell-off.

Conclusion: Severity and Liquidity Caveats

The lower circuit lock at a 4.99% loss for Par Drugs & Chemicals Ltd reflects a session dominated by unfilled supply and absent demand. The falling delivery volume suggests speculative selling rather than holder capitulation, but the liquidity constraints inherent in a micro-cap stock amplify the exit risk. The narrow intraday range at the circuit price and the break below the 5-day moving average confirm immediate weakness, while longer-term averages remain intact. This combination points to a fragile technical and liquidity position — after a 4.99% single-day loss at lower circuit, is Par Drugs & Chemicals Ltd approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today